Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-13
2005-12-13
Tsang, Cecilia J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S341000, C514S406000, C544S238000, C546S166000, C546S275700, C548S374100
Reexamination Certificate
active
06974813
ABSTRACT:
NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.
REFERENCES:
patent: 5698581 (1997-12-01), Kleemann et al.
patent: 5852046 (1998-12-01), Lang et al.
patent: 6492401 (2002-12-01), Hamanaka et al.
patent: 2144568 (1970-09-01), None
patent: 0708091 (1996-04-01), None
patent: 0787728 (1997-08-01), None
patent: 0622356 (1998-07-01), None
patent: 0803501 (2000-07-01), None
patent: WO 9426709 (1994-11-01), None
patent: WO 9827061 (1998-06-01), None
Takasaki, Koichiro, et al. 69: pp 977-994. 1973 “Hypoglycemic Activity of Certain Heterocyclic Acid Derivatives”, Nichi-Yakuri-shi (Folia pharmacol. Japan).
Guzman-Perez Angel
Hamanaka Ernest S.
Mularski Christian J.
Ruggeri Roger B.
Wester Ronald T.
Ashbrook Charles W.
Eck Steven R.
Robinson Binta
Tsang Cecilia J.
Warner-Lambert & Company
LandOfFree
N-[(substituted five-membered di-or triaza diunsaturated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[(substituted five-membered di-or triaza diunsaturated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[(substituted five-membered di-or triaza diunsaturated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3520590